You are here

Home / Resources / Key Material
Export 1061 results:
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
C
Linam, W. M., & Gerber M. A. (2007).  Changing epidemiology and prevention of Salmonella infections. The Pediatric Infectious Disease Journal. 26(8), 
Muller, D., Edwards M. L., & Smith D. W. (1983).  Changes in Iron and Transferrin Levels and Body Temperature in Experimental Airborne Legionellosis. The Journal of Infectious Diseases. 147, 2.
Muller, D.., Edwards M.. L., & Smith D.. W. (1983).  Changes in iron and transferrin levels and body temperature in experimental airborne legionellosis.. Journal of Infectious Diseases. 147, 302-307.
Muller, D., Edwards M. L., & Smith D. W. (1983).  Changes in iron and transferrin levels and body temperature in experimental airborne legionellosis. Journal of Infectious Diseases. 147, 302–307.
Muller, D., Edwards M. L., & Smith D. W. (1983).  Changes in iron and transferrin levels and body temperature in experimental airborne legionellosis. Journal of Infectious Diseases. 147,
(2015).  CFR - Code of Federal Regulations Title 21.
(2016).  Center for Advancing Microbial Risk Assessment CAMRA Microbial Risk Assessment Wiki .
Parent, M. A., Berggren K. N., Kummer L. W., Wilhelm L. B., Szaba F. M., Mullarky I. K., et al. (2005).  Cell-Mediated Protection against Pulmonary Yersinia pestis Infection. Infection and Immunity. 73, 11.
Dabritz, H., & Conrad P. (2010).  Cats and Toxoplasma: implications for public health. Zoonoses and Public Health. 57,
Tribble, D. R., Baqar S., Carmolli M. P., Porter C., Pierce K. K., Sadigh K., et al. (2009).  Campylobacter jejuni strain CG8421: a refined model for the study of Campylobacteriosis and evaluation of Campylobacter vaccines in human subjects. Clinical infectious diseases. 49, 1512–1519.
Tribble, D.. R., Baqar S.., Carmolli M.. P., Porter C.., Pierce K.. K., Sadigh K.., et al. (2009).  Campylobacter jejuni strain CG8421: a refined model for the study of Campylobacteriosis and evaluation of Campylobacter vaccines in human subjects. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. 49, 1512-1519.
Tribble, D. R., Baqar S., Carmolli M. P., Porter C., Pierce K. K., Sadigh K., et al. (2009).  Campylobacter jejuni Strain CG8421: A Refined Model for the Study of Campylobacteriosis and Evaluation of Campylobacter Vaccines in Human Subjects. Clinical Infectious Diseases. 49, 10.
Sjögren, E., Ruiz-Palacios G., & Kaijser B. (1989).  Campylobacter jejuni isolations from Mexican and Swedish patients, with repeated symptomatic and/or asymptomatic diarrhoea episodes. Epidemiology & Infection. 102, 47–57.
Vogt, RL., Sours HE., Barrett T., Feldman RA., Dickinson RJ., & Witherell L. (1982).  Campylobacter enteritis associated with contaminated water.. Annals of Internal Medicine. 96, 292–296.
Green, K. (2013).  Caliciviridae: The Noroviruses.
Mafart, P., Couvert O., Gaillard S., & Leguérinel I. (2002).  On calculating sterility in thermal preservation methods: application of the Weibull frequency distribution model. International journal of food microbiology. 72, 107–113.
B
Kambhampati, A., Koopmans M., & Lopman BA. (2015).  Burden of norovirus in healthcare facilities and strategies for outbreak control.
[Anonymous] (2013).  Burden of Norovirus Illness in the U.S..
[Anonymous] (2013).  Burden of Foodborne Illness: Findings.
[Anonymous] (2005).  Brock Biology of Microorganisms. (Madigan, M.., & J M., Ed.).
Smith, P. G., & Bradley R. (2003).  Bovine spongiform encephalopathy (BSE) and its epidemiology. British Medical Bulletin. 66, 185–198.
Mayon-White, RT., & Frankenberg RA. (1989).  Boil the water. The Lancet. 334, 216.
Korajkic, A., McMinn B. R., Shanks O. C., Sivaganesan M., G Fout S., & Ashbolt N. J. (2014).  Biotic interactions and sunlight affect persistence of fecal indicator bacteria and microbial source tracking genetic markers in the upper Mississippi river. Applied and environmental microbiology. 80, 3952–3961.
Jernigan, J. A., Stephens D. S., Ashford D. A., Omenaca C., Topiel M. S., Galbraith M., et al. (2001).  Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States.. Emerging infectious diseases. 7, 933.
Jernigan, J.. A., Stephens D.. S., Ashford D.. A., Omenaca C.., Topiel M.. S. >, Galbraith M.., et al. (2001).  Bioterrorism Related Inhalational Anthrax: The First 10 Cases Reported in the United States. Emerging Infectious Diseases. 7, 933-944.